Nothing Special   »   [go: up one dir, main page]

PT2855509T - Domínios de ligação à albumina de consenso não-natural - Google Patents

Domínios de ligação à albumina de consenso não-natural

Info

Publication number
PT2855509T
PT2855509T PT137935649T PT13793564T PT2855509T PT 2855509 T PT2855509 T PT 2855509T PT 137935649 T PT137935649 T PT 137935649T PT 13793564 T PT13793564 T PT 13793564T PT 2855509 T PT2855509 T PT 2855509T
Authority
PT
Portugal
Prior art keywords
binding domains
albumin binding
natural consensus
consensus albumin
natural
Prior art date
Application number
PT137935649T
Other languages
English (en)
Inventor
Jacobs Steven
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of PT2855509T publication Critical patent/PT2855509T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/31Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT137935649T 2012-05-25 2013-05-23 Domínios de ligação à albumina de consenso não-natural PT2855509T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261651642P 2012-05-25 2012-05-25
US201361776918P 2013-03-12 2013-03-12

Publications (1)

Publication Number Publication Date
PT2855509T true PT2855509T (pt) 2018-08-03

Family

ID=49622071

Family Applications (1)

Application Number Title Priority Date Filing Date
PT137935649T PT2855509T (pt) 2012-05-25 2013-05-23 Domínios de ligação à albumina de consenso não-natural

Country Status (16)

Country Link
US (3) US9156887B2 (pt)
EP (1) EP2855509B1 (pt)
JP (3) JP2015519345A (pt)
KR (1) KR102053674B1 (pt)
CN (1) CN104470944B (pt)
AU (2) AU2013266215B2 (pt)
BR (1) BR112014029409B1 (pt)
CA (1) CA2874646C (pt)
DK (1) DK2855509T3 (pt)
EA (1) EA036487B1 (pt)
ES (1) ES2670442T3 (pt)
HK (1) HK1209134A1 (pt)
IL (2) IL235808A (pt)
MX (1) MX355041B (pt)
PT (1) PT2855509T (pt)
WO (1) WO2013177398A2 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9695228B2 (en) 2012-11-21 2017-07-04 Janssen Biotech, Inc. EGFR and c-Met fibronectin type III domain binding molecules
CA2902789A1 (en) * 2013-03-14 2014-09-18 The Governing Council Of The University Of Toronto Scaffolded peptidic libraries and methods of making and screening the same
WO2016174575A1 (en) * 2015-04-29 2016-11-03 Mediolanum Farmaceutici S.P.A. A soluble chimeric interleukin-10 receptor and therapeutic use thereof
US10456442B2 (en) * 2015-06-18 2019-10-29 Albert Einstein College Of Medicine FGF receptor ligands for treating diabetes and obesity
WO2017081082A2 (en) * 2015-11-09 2017-05-18 Curevac Ag Optimized nucleic acid molecules
CN106699842B (zh) * 2015-11-17 2020-06-12 上海交通大学 一种新的抗炎小分子多肽及其应用
JP7091248B2 (ja) 2016-03-01 2022-06-27 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ 低減されたl-グルタミナーゼ活性および増強された安定性を有するl-アスパラギナーゼ変異体および融合タンパク質
WO2018111978A1 (en) 2016-12-14 2018-06-21 Janssen Biotech, Inc. Cd137 binding fibronectin type iii domains
AU2017378226A1 (en) 2016-12-14 2019-06-20 Janssen Biotech, Inc. CD8A-binding fibronectin type III domains
JP7332157B2 (ja) * 2017-01-24 2023-08-23 ノースウェスタン ユニバーシティ アンジオテンシン変換酵素2(ace2)の活性な低分子量変異体
AU2018313253B2 (en) 2017-08-11 2024-09-26 The Board Of Trustees Of The University Of Illinois Truncated guinea pig L-asparaginase variants and methods of use
JP7545894B2 (ja) 2018-03-13 2024-09-05 アフィボディ アクティエボラーグ 新規足場に基づくポリペプチド
KR102282240B1 (ko) * 2018-12-06 2021-07-28 경상국립대학교산학협력단 지속형 엑센딘-4 및 이의 용도
WO2021076574A2 (en) 2019-10-14 2021-04-22 Aro Biotherapeutics Company Fn3 domain-sirna conjugates and uses thereof
US11628222B2 (en) 2019-10-14 2023-04-18 Aro Biotherapeutics Company CD71 binding fibronectin type III domains
JP2023508885A (ja) * 2019-12-18 2023-03-06 アロ・バイオセラピューティクス・カンパニー 血清アルブミン結合性フィブロネクチンiii型ドメインおよびその使用
US12123036B2 (en) 2020-02-26 2024-10-22 Northwestern University Soluble ACE2 variants and uses therefor
EP4323409A2 (en) 2021-04-14 2024-02-21 ARO Biotherapeutics Company Cd71 binding fibronectin type iii domains
CN113336860B (zh) * 2021-06-02 2022-07-01 北京大学 一种具有靶向和长效功能的重组水蛭素融合蛋白及其编码基因和应用
WO2024102190A2 (en) * 2022-11-09 2024-05-16 Avitide LLC Affinity agents
WO2024130179A1 (en) 2022-12-16 2024-06-20 Repertoire Immune Medicines, Inc. T cell receptors binding hpv-16 epitopes

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267964B1 (en) 1989-08-01 2001-07-31 Affibody Technology Sweden Ab Stabilized protein or peptide conjugates able to bond albumin having extended biological half-lives
CA2135208C (en) * 1992-05-07 2009-06-30 Angus Robert Trowern Immunoglobulin binding proteins derived from l protein and their uses
WO1994012520A1 (en) 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
US6670127B2 (en) 1997-09-16 2003-12-30 Egea Biosciences, Inc. Method for assembly of a polynucleotide encoding a target polypeptide
DK1538206T3 (da) 1997-09-16 2010-07-12 Centocor Ortho Biotech Inc Fremgangsmåde til fuldstændig kemisk syntese og samling af gener og genomer
US20050287153A1 (en) 2002-06-28 2005-12-29 Genentech, Inc. Serum albumin binding peptides for tumor targeting
PT1240337E (pt) 1999-12-24 2007-01-31 Genentech Inc Métodos e composições para prolongar as meias-vidas de eliminação de compostos bioactivos
DK2190863T3 (en) 2007-07-31 2015-11-30 Affibody Ab New albumin binding compositions, methods and uses
JP5425775B2 (ja) 2008-06-30 2014-02-26 協和発酵キリン株式会社 抗cd27抗体
PL2356269T3 (pl) * 2008-10-31 2016-12-30 Kompozycje białek rusztowania oparte na domenie fibronektyny typu III, sposoby i zastosowania
WO2010092963A1 (ja) * 2009-02-10 2010-08-19 国立大学法人 琉球大学 薬物運搬体並びにこれを利用したアジュバントおよびワクチン
RU2562700C2 (ru) 2009-02-12 2015-09-10 Янссен Байотек, Инк. Композиции, способы получения и применение каркаса на основе домена фибронектина типа iii
EP2437767B1 (en) * 2009-06-01 2015-07-08 MedImmune, LLC Molecules with extended half-lives and uses thereof
EA024701B1 (ru) 2010-04-13 2016-10-31 Селлдекс Терапьютикс Инк. Антитела, связывающие cd27 человека, и их применение
WO2011137319A2 (en) * 2010-04-30 2011-11-03 Centocor Ortho Biotech Inc. Stabilized fibronectin domain compositions, methods and uses
US9695228B2 (en) * 2012-11-21 2017-07-04 Janssen Biotech, Inc. EGFR and c-Met fibronectin type III domain binding molecules

Also Published As

Publication number Publication date
DK2855509T3 (en) 2018-07-23
JP7166081B2 (ja) 2022-11-07
AU2013266215A1 (en) 2014-12-04
MX355041B (es) 2018-03-28
WO2013177398A3 (en) 2014-03-27
KR102053674B1 (ko) 2019-12-09
AU2013266215B2 (en) 2017-12-07
WO2013177398A2 (en) 2013-11-28
AU2017261625B2 (en) 2019-11-21
US9156887B2 (en) 2015-10-13
ES2670442T3 (es) 2018-05-30
JP2018171063A (ja) 2018-11-08
US20160083436A1 (en) 2016-03-24
EP2855509A2 (en) 2015-04-08
IL254652B (en) 2019-12-31
BR112014029409B1 (pt) 2022-11-29
CA2874646A1 (en) 2013-11-28
IL235808A (en) 2017-10-31
HK1209134A1 (en) 2016-03-24
US20130316952A1 (en) 2013-11-28
EP2855509B1 (en) 2018-05-02
EP2855509A4 (en) 2016-01-13
AU2017261625A1 (en) 2017-12-07
EA201590136A1 (ru) 2016-02-29
CN104470944A (zh) 2015-03-25
JP2015519345A (ja) 2015-07-09
CN104470944B (zh) 2021-09-14
EA036487B1 (ru) 2020-11-16
JP2021019595A (ja) 2021-02-18
CA2874646C (en) 2020-12-01
KR20150016585A (ko) 2015-02-12
US20180009854A1 (en) 2018-01-11
IL254652A0 (en) 2017-11-30
US10280200B2 (en) 2019-05-07
IL235808A0 (en) 2015-01-29
MX2014014384A (es) 2015-05-11
BR112014029409A2 (pt) 2017-08-15

Similar Documents

Publication Publication Date Title
IL254652B (en) Unnatural albumin binding sites
HK1211297A1 (en) Binding proteins comprising at least two repeat domains against her2 her2
IL240838A0 (en) Anti-3–lag binding proteins
HK1208707A1 (en) Cd3 binding polypeptides cd3
IL233793B (en) mica binders
HK1207656A1 (en) Albumin binding polypeptide
GB2506862B (en) Book
PL2912054T3 (pl) Polipeptyd wiążący albuminę
HK1205524A1 (en) Engineered conformationally-stabilized proteins
EP2793918A4 (en) HDC-SIGN LINK PEPTIDES
HK1204948A1 (en) Radiation-sterilization-resistant protein composition
GB201418608D0 (en) Peridinin-chlorophyll binding proteins
GB201213672D0 (en) Protein
GB201200563D0 (en) Binding molecule
HK1211952A1 (en) Recombinant protein
GB201203944D0 (en) Binding polypeptides
GB201214293D0 (en) Binding surfaces
GB201215901D0 (en) Protein modification
GB201200743D0 (en) Protein bridges
GB201103961D0 (en) Binding polypeptides
GB201217550D0 (en) Stoarage book
GB201200679D0 (en) Document binding system